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ABSTRACT The current study examines the associa-
tion between glucose induction of reactive oxygen
species (ROS), mitochondrial (Mt) depolarization, and
programmed cell death in primary neurons. In primary
dorsal root ganglion (DRG) neurons, 45 mM glucose
rapidly induces a peak rise in ROS corresponding to a
50% increase in mean Mt size at 6 h (P<0.001). This is
coupled with loss of regulation of the Mt membrane
potential (Mt membrane hyperpolarization, followed
by depolarization, MMD), partial depletion of ATP,
and activation of caspase-3 and -9. Glucose-induced
activation of ROS, MMD, and caspase-3 and -9 activa-
tion is inhibited by myxothiazole and thenoyltrifluoro-
acetone (P<0.001), which inhibit specific components
of the Mt electron transfer chain. Similarly, MMD and
caspase-3 activation are inhibited by 100 M bongkre-
kic acid (an inhibitor of the adenosine nucleotide
translocase ANT). These results indicate that mild
increases in glucose induce ROS and Mt swelling that
precedes neuronal apoptosis. Glucotoxicity is blocked
by inhibiting ROS induction, MMD, or caspase cleavage
by specific inhibitors of electron transfer, or by stabi-
lizing the ANT.—Russell, J. W., Golovoy, D., Vincent,
A. M., Mahendru, P., Olzmann, J. A., Mentzer, A.,
Feldman, E. L. High glucose-induced oxidative stress
and mitochondrial dysfunction in neurons. FASEB J. 16,
1738–1748 (2002)
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Increasing evidence indicates that mitochondria are
intimately associated with programmed cell death
(PCD) in neurons (for review, see ref 1). The mecha-
nism(s) leading to mitochondrial (Mt) dysfunction and
apoptosis in neurons is uncertain; however, oxidative
stress may be central to depolarization of the inner Mt
membrane potential (loss of the M), and may initiate
PCD. This association between oxidative stress and PCD
is important in the pathogenesis of several neurodegen-
erative diseases, such as Alzheimer’s disease, Hunting-
ton’s disease, the muscular dystrophies, and in models
of cerebral ischemia. Loss of the M leads to inner Mt
membrane depolarization (MMD) and release of cyto-
chrome c and other regulatory proteins from the Mt
(1). Release of cytochrome c into the cytosol activates
apoptosis-activating factor I (Apaf-1) and caspase-9,
with formation of a cytochrome c/caspase-9/Apaf-1
complex (the apoptosome) (1).
Previous studies in this and other laboratories show
that high glucose induces PCD in neurons both in vivo
and in vitro (2–6). In primary dorsal root ganglion
neurons (DRG) from diabetic rats, there is down-
regulation of Bcl-2 (3) and evidence of apoptosis (2, 3).
Several laboratories have shown in diabetic rats a loss of
DRG neurons, particularly large neurons, correspond-
ing to loss of the largest myelinated fibers, resulting in
neuropathy (2, 7, 8). Diabetic neuropathy in animals is
associated with induction of a variety of reactive oxygen
species (ROS) and may be ameliorated by antioxidant
treatment (9). Although a clear link between oxidative
stress and neuronal PCD is established for acute and
chronic neurodegenerative diseases, the mechanism(s)
by which high glucose induces neuronal PCD in animal
and culture models of diabetic neuropathy is unknown.
This study explores how oxidative stress and changes in
the M induce PCD in primary neurons. DRG cul-
tured in high glucose accumulate ROS, followed by Mt
swelling, initial Mt hyperpolarization, then depolariza-
tion and efflux of cytochrome c into the cytosol.
Cytochrome c efflux activates caspase-3 and -9 resulting
in DRG apoptosis. These changes are blocked by inhib-
itors of the Mt respiratory chain and stabilization of the
M, indicating that glucose activates the caspase
cascade in neurons by oxidative stress-induced Mt dys-
function.
MATERIALS AND METHODS
Mitotracker orange (CMTMRos), chloromethyl-dichlorodihy-
drofluorescein diacetate (CM-H2DCFDA), tetramethylrho-
damine ester (TMRM), and JC1 were obtained from Molec-
ular Probes, Eugene, OR. For ADP:ATP measurements, a
luciferase kit was obtained from Lumitech Ltd. (Nottingham,
UK). Bongkrekic acid (BKA) was purchased from Biomol
(Plymouth Meeting, PA), Boc-aspartyl (OMe)-fluoromethyl-
ketone (BAF) from Enzyme Systems Products (Dublin, CA),
and neurobasal medium, B27, and trypsin from Life Technol-
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ogies (Grand Island, NY). The CM1 antibody was a gift from
Dr. A. Srinivasan of IDUN Pharm., La Jolla, CA. CaspaTag
anti-active caspase-9 was from Intergen (Purchase, NY); cyto-
chrome c MAb (clone 6H2.B4 PharMingen) and secondary
antibodies were from Vector (Burlingame, CA). All other
chemicals were purchased from Sigma Chemical Co. (St.
Louis, MO).
DRG culture
Dissociated DRG were prepared and aseptically plated on
air-dried, collagen-coated plastic ACLAR dishes or plastic
12-well plates as described (2). To reduce the number of
contaminating Schwann cells and fibroblasts by 95%, neu-
rons were treated with 30 M 5-fluoro-2-deoxyuridine. Dis-
sociated DRG neurons were plated at density of 5000
neurons per ACLAR dish. DRG were incubated at 37°C with
5% carbon dioxide; initial plating and culture was in serum-
free B27 without antioxidants and neurobasal medium. For
all experiments, cultures were washed and cultured in a
defined medium containing neurobasal medium supple-
mented with 1.4 mM L-glutamine, 30 nM selenium, 10 nM
hydrocortisone, 10 nM -estriadiol, and 10 g/mL trans-
ferrin. We earlier reported that serum and insulin-free media
produce equal or superior neuronal growth and survival
(0–96 h) as media containing calf serum (2). Optimal DRG
survival and neurite growth require 25–30 mM basal glucose
(2), reflecting the fact that neurons have high metabolic
rates. Neurobasal media containing 25 mM glucose meets
these metabolic requirements. This concentration is subse-
quently called control glucose. A high glucose condition
contains at least 20 mM added glucose (total of 45 mM
glucose). DRG were cultured in control or high glucose
medium  100 M BKA or 3 M myxothiazole for 0–24 h.
These concentrations of BKA and myxothiazole have been
shown to have maximum efficacy in DRG neurons over 6–24
h without inducing PCD.
Measurement of ROS
Cell-permeant CM-H2DCFDA was dissolved in DMSO as a
concentrate and diluted to 0.1% DMSO. This concentration
of DMSO is nontoxic to DRG cultures, does not affect
measurements of oxidative stress or Mt dysfunction, and is
unlikely to act as a hydroxyl ion trap. In the presence of ROS,
intracellular esterases cleave acetate groups from CM-
H2DCFDA, trapping nonfluorescent 2, 7-dichlorofluores-
cein in the neuron (10). Subsequent oxidation yields fluores-
cent DCF, which detects transient rises in ROS, including
H202 and, in particular, peroxinitrites (10). To confirm that
DCF was able to detect increased oxidative stress within this
culture system, DRG in control medium were treated with 4
M antimycin A. Using confocal microscopy, DCF levels
peaked with antimycin A at 1 h compared with control. DCF
similarly showed a dose-dependent increase in DRG neurons
exposed to H2O2. Having established that DCF accurately and
sensitively measures ROS generation in cultured neurons,
DRG were coincubated with 2 M CM-H2DCFDA in the
presence of glucose treatment. Media pH was maintained at
uniform levels throughout the experiment. At the end of the
period measured, cultures were fixed with 4% paraformalde-
hyde and prepared as described (2). Using a Noran confocal
microscope fitted with Oz with Intervision (Noran Instru-
ments, Madison, WI), a z-series was examined and neuron
DCF pixel intensity was measured using a specific image
analysis macro written for NIH Image. To measure peak DCF
levels, scanned images of each neuron were obtained and
average pixel intensity for the neuron and peak intensity in
Mt in the scanned image were measured. As DCF changes
were maximal in Mt and showed a stronger association with
changes in ROS generation, Mt pixel intensity was used for
further analysis. The Mt pixel intensity was averaged and the
background fluorescence subtracted. Results were obtained
from at least 50 neurons/condition in each of six experi-
ments.
To confirm that glucose generates ROS, dihydroethidium
(DHE) conversion to ethidium by oxidation was measured.
The ratio of DHE:ethidium was determined using a fluorim-
eter (Fluoroskan Ascent II, Helsinki, Finland) and standard-
ized against DRG protein. DHE was measured using 355 nm
excitation and 430 nm emission, and ethidium was measured
using 518 nm excitation and 605 nm emission. Results were
obtained from 200,000 neurons/well using 12-well plates in
four separate experiments.
Measurement of Mt size
DRG neurons were loaded with CMTMRos using confocal
microscopy with 540 nm excitation. Each Mt is a complex
fractal-like network, making accurate analysis of volume dif-
ficult. Therefore, the maximum cross-sectional area was de-
termined from identification of each individual Mt through-
out the z-series. All distinguishable Mt at each step level in the
z-series were measured at the largest cross-sectional area of
the Mt. The size of the Mt was determined using the perim-
eter of visible CMTMRos and reflects the Mt area at the
measured level. Identical methods of identification and mea-
surement were applied to each Mt in each cell and in each
condition, thus reducing the effect of technical artifact. The
Mt areas were then averaged for each neuron and, where
necessary, results were first converted to a log normal distri-
bution before obtaining descriptive statistics or performing
tests of inference about the data set. Results were obtained
for 100 Mt in at least 10 randomly measured neurons per
condition. Experiments were repeated at least in triplicate.
Measurement of changes in the M
Three different dyes were used for the measurement of M:
TMRM ester, CMTMRos, and JC-1. Each dye was applied for
30 min at 37°C prior to analysis and pH was stable throughout
experiments. Uptake of TMRM ester (50 nM) was measured
in live DRG using fluorimetry (Fluoroskan Ascent II, Helsinki,
Finland) with 485 nm excitation and 590 nm emission.
Twelve-well plates with 200,000 neurons per well were used.
Results were corrected for the DRG protein concentration.
Uptake of CMTMRos (50 nM) was determined after washing
the cells with fresh media and fixation in 4% paraformalde-
hyde. Using the Noran confocal microscope, the mean pixel
intensity was obtained for each Mt and background intensity
values were subtracted (100 Mt/neuron and 10 neurons/
condition). JC1 (2.5 g/mL) was measured using confocal
microscopy and fluorimetry. Depending on the state of
polarization, this cell-permeant dye exists as a red fluorescent
aggregate (absorption: 488 nm; emission: 590 nm) at negative
membrane potentials (	
100 mV) and as a green fluores-
cent monomer (absorption: 488 nm emission: 530 nm) with
more positive membrane potentials (
100 mV). The 590/
530 nm ratios were obtained to characterize the M. To
establish the validity of TMRM, JC1, and CMTMRos in
accurately measuring changes in the M in DRG, neurons
were assessed as follows: with 10 M valinomycin, almost
complete depolarization was observed; with 10 M oligomy-
cin, there was hyperpolarization in control DRG but rapid
depolarization in high glucose-treated DRG with compro-
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mised ATP regulation; the uncoupling agent FCCP (2 M)
induced partial depolarization.
Measurement of ADP:ATP ratios
ATP and ADP levels were measured using a luciferase kit with
a luminescence plate reader (Fluroskan Ascent II, Lab-
systems, Helsinki). Equal numbers of DRG neurons
(200,000/well) were cultured in 12-well plates. After exposure
to treatment media for a specified time, cells were lysed in the
kit’s nucleotide-releasing reagent and transferred to 96-well
white-walled plates according to instructions. ATP was mea-
sured in the sample, then ADP was converted to ATP and the
measurement was repeated to permit the calculation of the
ratio of ADP:ATP. Results were then corrected for DRG
protein concentrations.
Immunohistochemistry for cytochrome c release, caspase-3,
caspase-9, and TUNEL staining
To measure cytochrome c translocation, DRG were first
incubated in CMTMRos as indicated above to localize the Mt.
DRG were then fixed with 4% paraformaldehyde, permeabil-
ized with Triton X-100, incubated in 1:500 of 0.1 mg/mL
cytochrome c MAb (clone 6H2.B4) for 2 h at 37°C, followed
by 10 g/mL FITC labeled secondary anti-mouse at room
temperature for 1 h. A Noran confocal microscope was used
to view cytochrome c translocation from the Mt.
Fixed DRG neurons were treated with rabbit anti-CM1
antibody (1:5000 of a 0.410 mg/mL working stock) overnight
at room temperature, then with 7.5 g/mL rhodamine-
conjugated goat anti-rabbit antibody for 1 h as described (2).
The nuclear chromatin was counterstained with 1 g/mL
bisbenzamide in PBS. The number of apoptotic neurons was
determined using a random grid counting system (2) on a
Zeiss axiophot 2 microscope (Carl Zeiss, Thornwood, NY)
with a 60 oil immersion objective. Caspase-9 was detected
with the carboxyfluorescein derivative of benzyloxycarbonyl
leucylglutamylhistidylaspartic acid fluoromethyl ketone FAM-
LEHD-FMK (CaspaTag). FAM-LEHD-FMK enters the cell and
irreversibly binds to caspase-9, and to a lesser extent to
caspase-4, -5, and -6. The percentage of cells with positive
specific fluorescence was measured as described above and
DRG TUNEL staining was performed (2).
Statistical analysis
Assumptions about the Gaussian distribution of data and
rules for transformation of nonnormative data were made as
described (2). Comparison of dependent variables was per-
formed using factorial analysis of variance. For graphic and
descriptive purposes, controls are expressed as 100%, and
experimental conditions are referenced as control  se.
RESULTS
PCD in vitro is dependent on the concentration
of glucose
To determine the optimal culture concentration of
glucose, DRG neurons were exposed to increasing
concentrations of glucose ranging from 10 mM total
glucose to 45 mM and cleavage of caspase-3 was mea-
sured (Fig. 1). The lowest level of CM1-positive neurons
was observed with 25–30 mM glucose (Fig. 1). In
contrast, even small increases in glucose of 10 mM
higher (40 mM) resulted in a 16% increase in the
number of CM1-positive neurons (P	0.001). Similarly,
concentrations of glucose 	25 mM resulted in in-
creased cleavage of caspase-3.
High glucose induces formation of ROS
in DRG neurons
DCF levels were measured in control neurons and after
exposure to 45 mM glucose. With high glucose there
was a 75% increase in the mean level of DCF compared
with the corresponding control value (Fig. 2). DCF
levels peaked at 3–4 h (P	0.001). Beyond 5 h, levels of
DCF decreased and by 48 h were slightly below control
levels (not statistically significant). With increased con-
centrations of added glucose of up to 150 mM, ROS
production increased. An additional 8% increase in
DCF levels with 150 mM glucose vs. 45 mM glucose was
observed (NS). With higher concentrations of glucose
(150 mM), DCF levels peaked earlier (	3 h) and
declined by 6 h. An increase in generation of ROS in
the cell culture model was confirmed with DHE fluo-
rescence measurements using a fluorimeter. DHE is
primarily a measure of superoxide generation. Using
measurement of DHE oxidation (ethidium:DHE) ratio,
the highest ratio was obtained at 3–4 h, with levels
twofold higher than control (Fig. 2B, P	0.001), fol-
lowed by a decline in levels by 5–6 h.
Increased glucose induces Mt enlargement
We have reported that DRG from hyperglycemic rats
have an increased number of swollen disrupted Mt (2).
The current study examined the time course and
extent of glucose-induced neuronal Mt swelling and
depolarization in cultured DRG. Mt size was measured
using confocal microscopic images of CMTMRos-
treated DRG neurons. CMTMRos is an aldehyde-fixable
Figure 1. Glucose induces a dose-dependent increase in
caspase-3 cleavage. DRG and increasing concentrations of
added glucose were cultured for 6 h, then stained for
activated caspase-3. Basal glucose indicates the total concen-
tration of glucose in the medium. Optimal neuronal survival
is observed with 25–30 mM basal glucose. With glucose
concentrations 	25 mM or 35 mM there is a progressive
increase in PCD.
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dye that allows measurement of Mt size and accurately
reflects the M in Mt (11). In the presence of 45 mM
glucose, the Mt were significantly enlarged compared
with control neurons. At 6 h the mean Mt area was
0.43  0.03 m2 for control DRG and 0.66  0.08 m2
for Mt from DRG treated with 45 mM glucose. In the
presence of this high glucose, mean Mt size (measured
Mt area) increased by 50% at 6 h (Fig. 3) and
by 100% at 24 h (P	0.001). At 6 h vs. 48 h, there is
greater variability in Mt size with high glucose. This is
due to differences in degree of swelling of individual Mt
as indicated by the larger se at 6 h vs. 48 h (Fig. 3). By
48 h, all the Mt are enlarged; there is less variability and
thus a progressive increase in mean Mt size. Increasing
concentrations of added glucose (45–300 mM) induce
a dose-dependent enlargement of Mt in DRG neurons.
With 150 mM glucose there is a 130% increase in mean
Mt size; with 300 mM glucose, mean Mt size more than
doubles (166% increase) at 6 h after exposure to high
glucose (P	0.0001).
Glucose-induced changes in the M
The change in M was assessed in DRG neurons
treated with high glucose using TMRM and fluorimetry
(Fig. 4). There was an initial twofold increase in the
M at 3 h, followed by a threefold decrease in the
M at 6 h (P	0.001). Depolarization continued for
up to 24 h. In Fig. 4, the small se values reflect the large
number of samples used in the analysis. Using confocal
measurement of CMTMRos, there was further evidence
of MMD at 6 h, with a decrease in CMTMRos levels to
66.4  7.7% of control (P	0.001). These results were
further confirmed with JC1 fluorimetry. The 590/530
ratio was 5.6 in control DRG neurons and 3.92 (70% of
control) in 45 mM glucose at 6 h. Using confocal
microscopy of JC1, the 590/530 ratio was 46  9% of
control at 6 h (P	0.001).
Figure 2. Glucose induces production of ROS. A) DRG  45
mM glucose were cultured for up to 48 h in 2 M CM-
H2DCFDA. Fluorescent DCF was measured using confocal
microscopy. Results were obtained from 5 experiments stan-
dardized against control values at 0 h. With added glucose,
results are expressed as % control at each time point (1–48
h). In control media (containing 25 mM glucose), results at
1–48 h are expressed as % control 0 h. There was no statistical
change in control values after 48 h. In 45 mM glucose there
was an initial increase in the production of ROS (mean DCF
levels) that peaked at 3–4 h, then declined, corresponding to
increased neuronal death. B) DRG neurons in culture were
exposed to 45 mM glucose for 0–6 h. DHE (3 M) oxidation
to ethidium was measured using fluorimetry to determine
superoxide production during peak glucose-induced ROS
generation. Results are expressed as the ethidium:DHE ratio.
The ratio in controls remained at the 0 h value for the next
6 h.
Figure 3. High Glucose induces a dose-dependent enlarge-
ment of DRG Mt and Mt membrane depolarization. In 45 mM
glucose there is a progressive increase in mean Mt size up to
48 h. DRG neurons were treated with 5 M mitotracker
orange, fixed, and quantified by confocal microscopy. Values
for control neurons are plotted as % control at time 0 h.
Values for DRG treated with added glucose are plotted as %
of corresponding control at time points 0–48 h. Plotted
values represent mean  se.
Figure 4. High glucose induces initial hyperpolarization,
followed by depolarization of the M. The graph indicates
the change in TMRM fluorescence (relative intensity units,
RIU) in DRG neurons in 45 mM or control (25 mM) glucose
as a % of control. Fluorescence was measured using fluorim-
etry and represents data from 4 experiments. Peak hyperpo-
larization is seen at 3 h, followed by depolarization 5 h after
exposure to high glucose. There was no significant change in
TMRM fluorescence in control neurons during this period.
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Glucose increases the ADP:ATP ratio
When DRG were exposed to an increased glucose load
there was a rapid increase in the ADP:ATP ratio at 0.5 h
to 2.74 0.23, with a decrease in absolute levels of ATP
(Fig. 5). By 1 h the ratio had started to fall and was
accounted for mainly by a fall in absolute ATP levels, to
0.13 chemiluminescent units vs. 0.32 units in the con-
trol DRG (P	0.0001). The decrease in the ADP:ATP
ratio corresponded to hyperpolarization of the M.
The decrease in the ADP:ATP ratio continued until 5 h,
followed by an increase in the ratio corresponding to
depolarization on the M. In control neurons, the
ADP:ATP ratio remained stable at the 0 h level through-
out the experiment.
In DRG neurons exposed to glucose concentrations
of	25 mM such as relative “hypoglycemia,” there was a
decrease in absolute ATP levels. DRG neurons were
cultured in 5 mM glucose or 25 mM (control) condi-
tions over 6 h. By 3 h there was a 60% decrease in total
ATP levels compared with control neurons (mean of 3
separate experiments).
High glucose induces cytochrome c translocation
from the Mt to the cytosol
The next series of experiments addressed the question
of whether high glucose induces translocation of cyto-
chrome c from the Mt to the cytosol, an initiator event
in PCD (1). Colocalization of CMTMRos and cyto-
chrome c was used to visualize Mt containing cyto-
chrome c (Fig. 6). In control neurons, cytochrome c
colocalizes with the Mt (Fig. 6a). In the presence of 45
mM glucose, the Mt are enlarged and there is translo-
cation of cytochrome c to the cytosol (Fig. 6b), consis-
tent with initiation of PCD. As opposed to epifluores-
cent microscopy, with high magnification confocal
microscopy released cytochrome c is visualized as dis-
crete staining, possibly due to colocalization with the
apoptosome.
Glucose induces caspase-3 cleavage and apoptosis
Having established that glucose mediates ROS accumu-
lation and Mt swelling in DRG, we next asked whether
glucose-induced caspase-3 cleavage and apoptosis in
DRG neurons. In the presence of 45 mM glucose,
punctate positive CM-1 antibody staining was observed
in the cytosol of DRG neurons exposed to excess
glucose, consistent with the presence of caspase-3 cleav-
age (Fig. 7A). This was coupled with evidence of
chromatin condensation in DRG nuclei, consistent with
apoptosis (Fig. 7A). There was a progressive increase in
caspase-3 cleavage after exposure to 45 mM glucose. By
6 h the cleaved caspase-3 level had increased by 40%
(Fig. 7B) compared with timed controls (P	0.0001),
corresponding to the time point of maximal MMD. In
comparison, there was no statistical difference between
control caspase-3 levels at 0–24 h. The pan-caspase
inhibitor BAF inhibited neuronal cell death in the
presence of high glucose (Fig. 7C). With 45 mM
glucose there was a 36% increase in the number of
apoptotic neurons above control (P	0.01) and a 66%
increase with 150 mM added glucose (P	0.001, data
Figure 5. Effect of high glucose on the ADP:ATP ratio. The
graph indicates time-related changes in the ADP:ATP ratio
after exposure to 45 mM glucose for 0–12 h. The 0 h time
point is representative of the control ADP:ATP ratio, which
remained stable over 12 h. Results are representative of 4
separate experiments.
Figure 6. High glucose induces cytochrome c translocation
from the Mt to the cytosol. DRG cultures were treated for 6 h
with a) control media (25 mM glucose) or b) 45 mM glucose.
The top row (ai–bi) indicates Mt staining (red with white
arrowheads) with CMTMRos in single DRG neurons, the
second row (aii–bii) indicates cytochrome c staining (green
with white arrows), and the third row (aiii–biii) overlay of
cytochrome c and Mt. Mt (white arrowheads) and cytochrome
c staining (white arrows) are superimposed (yellow), indicat-
ing that cytochrome c is maintained in the Mt (normal state)
(aiii). Functional Mt are more numerous and smaller in the
control neuron. biii) Mt exposed to high glucose for 6 h
(white arrowheads) are enlarged and fewer compared with
control. Cytochrome c (white arrows) has been released from
the Mt into the cytosol, consistent with initiation of PCD.
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not shown). In contrast, 100 M BAF maintained the
percent apoptotic neurons at control levels even in the
presence of high glucose.
BKA inhibits Mt membrane depolarization
and caspase-3 cleavage
The next series of experiments determined whether
inhibition of the adenine nucleotide translocase/volt-
age-dependent anion channel (ANT/VDAC) complex
on the Mt membrane prevented Mt swelling, caspase
cleavage, and cell death. BKA is an inhibitory ligand for
the Mt ANT (12) and causes prolonged inhibition of
MMD. To determine whether stabilization of the M
in the presence of high glucose prevented cleavage of
caspase-3 and PCD, DRG neurons were treated with 100
M BKA. Data were standardized against control sam-
ples that represent 100% (Fig. 8A). There was a 54%
increase in the mean Mt size at 6 h with 45 mM glucose
compared with control (P	0.001). In the presence of
45 mM glucose, 100 M BKA inhibited Mt swelling,
maintaining mean Mt size at control levels. After 24 h,
BKA still inhibited Mt swelling induced by 45 mM
added glucose (Fig. 8A), but less effectively than at 6 h.
There was no significant difference in Mt size in control
DRG neurons  100 M BKA.
In contrast to Mt size, measurements of Mt pixel
intensity revealed a reduction in Mt CMTMRos inten-
sity reflecting loss of the M with high glucose (11).
There was a 15% reduction in the Mt intensity (Fig. 8B)
compared with control Mt intensity at 6 h (P	0.05) and
a 32% reduction at 24 h (P	0.001). Thus, 45 mM
glucose-induced progressive MMD. In contrast, addi-
tion of 100 M BKA completely inhibited MMD in-
duced by 45 mM glucose at 6 h. At 24 h, BKA partially
inhibited MMD, but was not statistically different from
control values. As expected from inhibition of the ANT,
BKA induces mild hyperpolarization of the Mt mem-
brane in control neurons, but stabilization of the M
prevents subsequent depolarization observed with high
glucose alone (Fig. 8B). Even with redosing at 12 h,
BKA less effectively inhibited Mt swelling and MMD at
24 h vs. 6 h. The initial rise in caspase-3 cleavage with
added glucose was blocked by BKA at 6 h. With 45 mM
added glucose and BKA, there were only 6% apoptotic
neurons vs. 3% with 45 mM added glucose alone
(P	0.001) and 7% in control (Fig. 8C).
To determine whether BKA inhibition of PCD was
independent of ROS generation, DCF levels were mea-
sured using confocal microscopy. BKA increased gen-
eration of ROS. Mean DCF levels were 26% higher with
high glucose and BKA than with high glucose alone.
Under control conditions, DCF levels were 31% higher
in the presence of BKA (mean of 3 separate experi-
ments).
Myxothiazole inhibits glucose-induced oxidative stress
and Mt dysfunction
To determine whether inhibition of ROS generation
prevents Mt dysfunction and initiation of PCD in the
presence of high glucose, the generation of Mt oxida-
tive species was blocked using myxothiazole. Myxothia-
zole inhibits the Mt respiratory chain at cytochrome b-c1
(13). In the presence of 45 mM added glucose, there
was a 20% increase in the mean DCF level in DRG
neurons at 6 h (P	0.001), indicating increased produc-
tion of ROS (Fig. 9A). At 12 h, DCF had returned to
control levels as indicated in Fig. 2. At 6 h in the
Figure 7. Increasing concentrations of glucose induce cleav-
age of caspase-3 and apoptosis that is blocked by pancaspase
inhibitors. A) Increased glucose induces cleavage of caspase-3
in cultured DRG neurons. DRG neurons were cultured in i)
control media or ii) media containing 45 mM glucose. After
6 h, the cultures were fixed and stained with 5 g/mL CM1 to
indicate cleaved (active) caspase-3 (orange-red), and 1
g/mL bisbenzamide to indicate nuclear chromatin (blue).
i) Immunofluorescent image showing normal diffuse nuclear
staining in the DRG neuron (blue). ii) Immunofluorescent
image showing cleaved caspase-3 in the cytoplasm (white
arrows) with some of the nuclei showing aggregation of
chromatin consistent with apoptosis (white arrowheads).
Panel ii shows high magnification of a single DRG neuron
with punctate diffuse CM1 staining (cleaved caspase-3) in the
cytoplasm, with chromatin clumping consistent with dissolu-
tion of the nucleus (white arrowhead). B) High glucose
induces activation of caspase-3 in neurons. Cultured DRG
neurons were exposed to 45 mM added glucose for 0–24 h.
Neurons were stained with the CM1 antibody, which mea-
sures cleaved caspase-3 in the neuron. The % of CM1-positive
neurons increases with time up to 24 h. In comparison there
was no significant change in controls from 0 to 24 h. C)
Inhibition of the cysteine protease PCD cascade by BAF
prevents high glucose-induced apoptosis in rat DRG neurons.
Dissociated DRG neurons cultured in defined serum-free
media were exposed for 24 h to high glucose  100 M BAF.
The % apoptotic neurons increased to 45% with 45 mM
glucose. With 100 M BAF there was complete inhibition of
neuronal cell death. **P 	 0.01.
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presence of 45 mM glucose, 3 M myxothiazole main-
tained the mean DCF at 98.2  3.3% of control (Fig.
9A). The DCF level with high glucose and myxothiazole
was significantly below DCF levels with 45 mM glucose
alone (P	0.001).
As previously observed, 45 mM glucose increased
mean Mt size progressively over 24 h. In contrast, 3
M myxothiazole inhibited Mt swelling; even at 24 h,
compared with controls, the mean Mt size was not
statistically different (Fig. 9B). Myxothiazole also
stabilized the M. Using 45 mM glucose and CMT-
MRos, mean Mt intensity decreased by 34% at 6 h
(P	0.001) and 39% at 24 h (P	0.001), consistent
with MMD. In contrast, when myxothiazole was
added to high glucose, Mt intensity remained at
102% of control at 6 h and 104% at 24 h. Using
TMRM and 45 mM glucose, myxothiazole blocked
initial glucose-induced Mt membrane hyperpolariza-
tion: TMRM levels were 3% below control values at
the peak of glucose-induced hyperpolarization (3 h).
Subsequently, myxothiazole prevented MMD ob-
served with high glucose at 6 h, probably due to
initial ATP synthase reversal. In both control and
high glucose-treated cultures, addition of myxothia-
zole eventually led to depolarization of the M
at 24 h.
Figure 9. Inhibition of Mt ROS generation by myxothiazole
blocks Mt enlargement and depolarization. A) Myxothiazole
inhibits the production of Mt ROS. DCF levels are expressed
as % of the corresponding control value. In the presence of
45 mM glucose, there was a 20% increase in the mean DCF
level in DRG neurons at 6 h (P	0.001), indicating increased
production of ROS. At 6 h, 3 M myxothiazole in the
presence of 45 mM glucose maintained the mean DCF at
98.2 3.3% of control (P	0.001). There was no difference in
DCF levels between control and control  myxothiazole. B)
Myxothiazole inhibits Mt enlargement at 6 and 24 h in DRG
neurons with high glucose. In the presence of 45 mM glucose,
3 M myxothiazole maintains Mt size at 107% of control
values at 6 h and 106% of control values at 24 h (not
significantly different from control).
Figure 8. Inhibition of Mt membrane depolarization by BKA
inhibits Mt enlargement and caspase cleavage. A) BKA inhib-
its Mt swelling in DRG neurons induced by 45 mM added
glucose. DRG neurons were treated with 45 mM glucose 
100 M BKA for 6–24 h, 5 M CMTMRos for 30 min, then Mt
size was measured. With 45 mM glucose at 6 h there was a
54% increase in mean Mt size and a 75% increase at 24 h
compared with controls (P	0.001). Glucose-induced enlarge-
ment of Mt was blocked by BKA. There was no statistically
significant differences between control, control  BKA, and
glucose  BKA at 24 h. B) BKA inhibits loss of Mt intensity
dependent on the M. With 45 mM glucose, there was a
15–32% decrease in mean Mt intensity compared with control
between 6 and 24 h. BKA maintained Mt intensity at control
levels at 6 h consistent with inhibition of the ANT/VDAC
complex and maintenance of the M. By 24 h BKA less
effectively inhibited glucose-induced MMD and mean Mt
intensity was reduced but this was not statistically significantly
different from control levels. C) BKA blocks glucose-induced
cleavage of caspase-3 in DRG neurons measured by CM1
antibody staining. DRG neurons were treated with 45 mM
extra glucose 100 M BKA for 6 h. BKA acts by blocking the
ANT/VDAC complex of the Mt and prevents loss of the M.
In the presence of BKA there is reduced CM-1 staining even
in the presence of 45 mM glucose, indicating that inhibition
of Mt depolarization is critical in preventing PCD. For all
graphs, *P 	 0.05, ***P 	 0.001.
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Myxothiazole inhibits glucose-induced caspase-3
and -9 cleavage
Myxothiazole also inhibited cleavage of upstream initi-
ator caspase-9 (Fig. 10A), which is released early in
initiation of PCD (1, 9). With 45 mM glucose, there was
increased binding of the carboxyfluorescein substrate
FAM-LEHD-FMK, which preferentially binds to active
caspase-9 and not caspase-3. Cleavage of caspase-9 was
blocked by 3 M myxothiazole compared with control
(P	0.001) (Fig. 10B). At both 6 and 24 h, 3 M
myxothiazole inhibited cleavage of caspase-3 induced
by 45 mM glucose (Fig. 10C). At 6 h, caspase-3 cleavage
in glucose  myxothiazole conditions was not statisti-
cally different from controls. At 24 h, myxothiazole
significantly reduced glucose-induced caspase-3 cleav-
age, but levels were slightly above those seen in the
controls (P	0.05).
TTFA inhibits glucose-induced Mt dysfunction
and PCD
To determine whether inhibition of Mt complexes
other than complex III blocked Mt enlargement and
caspase activation, DRG neurons cultured in 45 mM
glucose were treated with the Mt complex II inhibitor
TTFA (Succinate-Q Reductase). TTFA blocked MMD
more effectively than Mt enlargement. In 45 mM
glucose, there was an increase in Mt size to 166% of
control (P	0.001), but 5 M TTFA maintained Mt size
at 121% of control values at 6 h (P	0.01 compared with
control). With 45 mM added glucose, there was a 31%
decrease in mean Mt intensity at 6 h consistent with
depolarization (P	0.001). TTFA partially blocked glu-
cose-induced Mt membrane depolarization to 93% of
control at 6 h (not significantly different from control).
TTFA alone did not significantly alter control Mt
intensity levels. TTFA blocked caspase-3 cleavage up to
24 h: control: 8%; 45 mM glucose: 30%; glucose 
TTFA: 10% (NS compared with control).
DISCUSSION
In the current study, glucose induces a dose-dependent
effect on cleavage of caspases. With a total in vitro
concentration of 25–30 mM glucose, there is optimal
DRG neuronal survival. This relatively high concentra-
tion of basal glucose most likely reflects the increased
energy requirements and metabolic rate of DRG com-
pared with nonneuronal cells. Glucose concentra-
tions 	 25 mM rapidly induce ATP depletion and an
increase in caspase-3 cleavage. Use of 25 mM glucose in
vitro is consistent with requirements reported for cen-
tral and peripheral nervous system neuronal cultures
(2, 14, 15) but higher than in vivo levels, where high
metabolic requirements are maintained by continuous
perfusion of neurons and large glucose reserves. Simi-
lar to results with reduced glucose levels, basal glucose
concentrations  25 mM induce PCD. These studies
confirm our previous findings in animal and cell cul-
ture models of diabetes using TUNEL staining (2, 3).
Thus, in vitro as in vivo, variations in basal glucose as
small as 10 mM induce neuronal injury; however,
unlike in vivo studies, the in vitro system permits
detailed mechanistic studies of glucose generated oxi-
dative stress.
As expected from the evidence of PCD in DRG
neurons, there is loss of 14–21% of total DRG neu-
rons in diabetic rats (2, 7), although there is variation
between affected animals and the result does not reach
statistical significance. However, if only the largest DRG
neurons are assessed in chronically diabetic animals,
there is loss of 43% of the largest neurons in diabetic
compared with nondiabetic animals (8). This corre-
Figure 10. The cytochrome b-c1 inhibitor myxothiazole blocks
cleavage of caspase-3 and -9. A) DRG neurons were cultured
in i) control media (25 mM glucose), ii) 45 mM glucose, or
iii) 45 mM glucose and 3 M myxothiazole for 6 h. The image
shows phase-contrast images (top row) and matched epifluo-
rescent images (bottom row). With added glucose there was
an increase in measured cleaved caspase-9 (ii) compared with
control DRG neurons treated with myxothiazole. B) With 45
mM added glucose at 6 h, % caspase-9-positive DRG neurons
was increased to 43% vs. 8% in control neurons with 25 mM
glucose (P	0.001) and 14% with added myxothiazole. There
were no statistical differences between control and myxothia-
zole-treated groups. C) The % caspase-3-positive DRG neu-
rons were determined using CM1 antibody at 6–24 h. Com-
pared with control, there is a 41% increase in caspase-3-
positive neurons with 45 mM glucose at 6 h and 56% at 24 h.
Caspase-3 activation with 45 mM added glucose and myxo-
thiazole was marginally above control at 6 h (not statistically
significant). At 24 h there was only partial inhibition of
caspase-3 cleavage by myxothiazole (13% control, P	0.05).
For all graphs, *P 	 0.05, ***P 	 0.001.
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sponds to loss of 53% of the largest myelinated fibers in
chronically diabetic animals (7). Our own findings
indicate an increase in oxidative injury in DRG neurons
in diabetic rats, providing a pervasive argument that
increased ROS is associated with neuronal loss and
development of sensory neuropathy. In the current
study, high glucose generates ROS coupled with hyper-
polarization of the M, followed by MMD, which is
temporally related to an increase in ADP:ATP ratios
and an absolute decrease in ATP levels. This in turn is
coupled with cytochrome c release from the intermito-
chondrial membrane space and cleavage of caspase-3
and -9, resulting in DRG apoptosis. Histological Mt
disruption and induction of PCD by high glucose have
been confirmed in vivo in DRG neurons and are not
related to hyperosmolarity at the concentration used in
this study (45 mM) (2). Whereas high glucose increases
ROS and destabilizes the M, inhibitors of the Mt
electron transfer chain or of proton transfer block
oxidative stress, MMD, and PCD induced by high
glucose. This concept is supported in neurons by recent
findings in bovine aortic endothelial cells (13); in-
creased cellular production of ROS occurs primarily in
the Mt through the electron transport chain, and ROS
generation is a causal link between high glucose and
PCD.
Increased metabolic flux in the Mt due to high
glucose, coupled with reduction of NAD to NADH,
results in increased formation of ROS such as superox-
ides, peroxinitrites, and highly reactive hydroxyl radi-
cals (9). These ROS are associated with membrane lipid
peroxidation, nitration of proteins, including tyrosine
residues, and degradation of DNA, all of which are
associated with induction of apoptosis (1, 2). Accumu-
lation of NADH coupled with failure of the Mt creatine
phosphate pump to regenerate ATP from ADP also
results in disruption of the Mt electron transfer chain
and depletion of ATP (13) associated with apoptosis. In
this study, there was an initial increase in ADP:ATP
ratios and a decrease in total ATP 1 h after exposure to
high glucose. The initial ATP decline is followed by an
increase in ATP levels along with a decrease in ADP:
ATP ratios at 3 h. This increase in ATP levels is coupled
with Mt hyperpolarization, presumably due to in-
creased proton pumping across the inner Mt mem-
brane (13, 16, 17). By 6 h, ATP levels are depleted,
similar to changes in ATP observed previously in
chronic neuropathy in diabetic animals (18). This
increase in the ADP:ATP ratio at 6 h corresponds to
MMD and initiation of PCD. In contrast to these late
events, early Mt membrane hyperpolarization corre-
sponds to peak generation of ROS. With an increase in
proton gradient, the electrochemical potential will
prolong the life of superoxide-generating electron
transport intermediates such as ubisemiquinone (13).
Thus, hyperpolarization of the inner Mt membrane
coupled with impaired creatine phosphate pumping of
ADP will disrupt the electron transfer chain and in-
crease ROS generation.
One of the key events coupled with ROS generation
is Mt swelling. In this study, with 45 mM glucose, there
is a 50% increase in mean Mt size at 6 h, corresponding
to the peak increase in ROS. Confocal microscopy of
serial sections of the DRG and previous electron mi-
croscopy (2) indicate there is true Mt enlargement and
not simply Mt fusion. Furthermore, the size of control
and high glucose-treated Mt measured in this study
matches the increase in Mt size observed in vivo using
transmission electron microscopy (2, 19). Mt swelling is
associated with a reduction in the mean M. Mt
permeability transition occurs with opening of the
ANT/VDAC channel spanning the inner and outer Mt
membranes. This results in swelling, which in turn
disrupts the integrity of the outer Mt membrane (20).
These events culminate in MMD and release of pro-
apoptotic factors such as cytochrome c into the cyto-
plasm that activate the caspase cascade (1). Inhibition
of the ANT/VDAC channel also inhibits flux of anions
across the inner Mt membrane, which initially stabilizes
the M but will eventually disrupt chemiosmotic ho-
meostasis in the Mt, and deplete the cell of ATP (12). In
this study, Mt swelling and reduction in the M induced
by high glucose are both blocked by BKA, which inhibits
opening of the ANT and stabilizes the inner Mt mem-
brane. In the presence of high glucose, BKA inhibits
downstream cleavage of caspase-3, indicating that glucose-
induced MMD and swelling precede cleavage of caspases.
Unlike cyclosporin, BKA is a specific ligand for the ANT
that inhibits opening of the ANT (21). Even though this
induces mild hyperpolarization of the M, BKA works
primarily by stabilizing the inner Mt membrane (21), thus
confirming that MMD is associated with PCD. As ex-
pected, the mild hyperpolarization induced by BKA is
associated with an increase in ROS generation; thus, BKA
inhibition of PCD at 6 h is independent of its effect on
ROS. At 24 h, BKA is less effective in inhibiting PCD,
consistent with a proapoptotic induction of ROS and
depletion of ATP.
Although stabilization of the M is able to tempo-
rarily block PCD, more effective inhibition of PCD is
achieved by regulation of the Mt electron transfer
chain. Four enzyme complexes (I-IV) permit transfer of
electrons through the transport chain. In the current
study, inhibition of Mt complex III at cytochrome b-c1
by myxothiazole (13) not only blocked glucose-induced
generation of ROS such as peroxinitrites, but also
prevented activation of initiator and effector caspases at
6 h. Myxothiazole blocks electron transport by inhibit-
ing electron flow in the Q cycle. Though this will
reduce ATP synthesis, neurons have sufficient glycolytic
capacity to survive for at least 6 h. More important,
myxothiazole is known to block Q cycle/complex III-
mediated ROS production when Mt are oxidizing com-
plex II substrates. Prevention of PCD is most likely
explained by the ability of myxothiazole to inhibit ROS
generation coupled with prevention of initial Mt hyper-
polarization, followed by rapid depolarization. Inhibi-
tion of MMD by myxothiazole is probably related to
reversal of ATP synthase. This is supported by the
finding that oligomycin, which inhibits ATP synthase,
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causes MMD after 6 h when used in the presence of
myxothiazole in DRG. At 6 h, myxothiazole blocks
glucose-induced cleavage of caspase-9 and -3. This
effect corresponds to the ability of myxothiazole to
inhibit glucose-induced hyperpolarization, followed by
depolarization of the M, and with inhibition of
glucose generated ROS. At 24 h, even though rapid
MMD was blocked, there was a slight increase in caspase
cleavage even in the presence of myxothiazole, an event
associated with a reduction in glycolytic capacity.
Similar to results obtained with myxothiazole, an-
other inhibitor of the electron, transfer chain reduces
induction of PCD. TTFA inhibits Mt complex II and has
uncoupling properties, although in this study TTFA did
not exhibit strong uncoupling effects. TTFA blocked
generation of ROS in neurons, similar to observations
in endothelial cells (13, 22), and partially reduced
glucose-induced Mt enlargement and caspase-3 cleav-
age, although this was less complete than with myxo-
thiazole. Rotenone, which only partially inhibits trans-
fer of electrons from complex I, is ineffective in block-
ing generation of ROS in cells exposed to high glucose
(13). Overall, the data with electron transfer chain
inhibitors are consistent with a model in which a
hyperglycemia-induced increase in electron transfer
donors from the tricarboxylic acid cycle (NADH and
FADH2) causes hyperpolarization of the M by pump-
ing protons across the Mt inner membrane. In turn,
this drives reduction of O2 to generate superoxide
anions (13, 17, 23).
The glucose-induced rise in oxidative stress is associ-
ated with translocation of cytochrome c from the Mt
into the cytosol, an event that precedes initiation of
PCD (1). A frequent, but not invariable, requirement
for translocation of cytochrome c from the intermito-
chondrial space to the cytosol is either Mt hyperpolar-
ization or MMD (1). Cytochrome c release from the Mt
is related to an intact permeability transition pore and
may be released from Mt even in the presence of a
functional outer Mt membrane, possibly by regulation
of pore forming sites by Bax and Bcl-2 (1). In sympa-
thetic neurons, colocalization of cytochrome c within
intact Mt is associated with punctate staining, similar to
our findings in DRG neurons. When cytochrome c is
translocated in the cytosol, there is loss of focal Mt
staining (24) using light microscopy, although colocal-
ization with the apoptosome may occur, a structure
similar in size to a ribosome. This probably accounts for
the discrete staining observed in the current study
using high magnification confocal microscopy.
Translocation of cytochrome c is associated with
formation of an apoptosome with pro-caspase-9 and
Apaf-1 (1, 25). Subsequent cleavage of pro-caspase-9
results in downstream cleavage of effector caspases such
as caspase-3 or nuclear translocation, with subsequent
DNA cleavage. In DRG neurons exposed to high glu-
cose, there is a fourfold increase in cleavage of both
initiator caspases such as caspase-9 and effector
caspases like caspase-3. Cleavage occurs within 6 h after
exposure to 45 mM glucose, but follows MMD. This is
consistent with activation of caspases and downstream
targets by an intrinsic PCD pathway. Cleavage of both
initiator and effector caspases was blocked by inhibitors
of the Mt electron transfer chain.
In summary, our study demonstrates that high glu-
cose mediates production of ROS and oxidative stress
in DRG that parallels changes in Mt size and function.
Mt enlarge, hyperpolarize, and depolarize; these effects
are blocked by myxothiazole and TTFA, inhibitors of
ROS formation. Changes in the M correspond not
only to generation of ROS, but also to partial depletion
of ATP, an event that is coupled to apoptosis. Together,
the increase in ROS and impaired regulation of oxida-
tive stressors result in PCD of DRG and provides a
mechanism to explain how impaired regulation of peak
glucose levels leads to ROS-induced injury in diabetic
neuropathy.
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